DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 913 filers reported holding DANAHER CORPORATION in Q2 2014. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $225,000 | -7.0% | 894 | -1.8% | 0.06% | -17.4% |
| Q4 2022 | $242,000 | -99.9% | 910 | +16.2% | 0.07% | +13.1% |
| Q3 2022 | $202,000,000 | -4.7% | 783 | +8.3% | 0.06% | +19.6% |
| Q1 2022 | $212,000,000 | -13.8% | 723 | -3.5% | 0.05% | +2.0% |
| Q4 2021 | $246,000,000 | -14.0% | 749 | -20.2% | 0.05% | -10.7% |
| Q3 2021 | $286,000,000 | -5.0% | 939 | -73.7% | 0.06% | -56.9% |
| Q2 2015 | $301,000,000 | -8.2% | 3,568 | -7.8% | 0.13% | -4.4% |
| Q1 2015 | $328,000,000 | +98695.2% | 3,868 | 0.0% | 0.14% | -2.2% |
| Q4 2014 | $332,000 | +12.9% | 3,868 | 0.0% | 0.14% | +8.6% |
| Q3 2014 | $294,000 | -99.9% | 3,868 | 0.0% | 0.13% | -7.2% |
| Q2 2014 | $305,000,000 | +5.2% | 3,868 | 0.0% | 0.14% | -2.8% |
| Q1 2014 | $290,000,000 | -3.0% | 3,868 | 0.0% | 0.14% | -3.4% |
| Q4 2013 | $299,000,000 | +111467.2% | 3,868 | 0.0% | 0.15% | +4.3% |
| Q3 2013 | $268,000 | +9.4% | 3,868 | 0.0% | 0.14% | +7.6% |
| Q2 2013 | $245,000 | – | 3,868 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |